Evidence map›Paper›PMID 24463518›Full record

ArticleNature2014

Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development.

Xindong Liu, Xin Chen, Bo Zhong, Aibo Wang, Xiaohu Wang, Fuliang Chu, Roza I Nurieva, Xiaowei Yan, Ping Chen, Laurens G van der Flier and 8 more

Abstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 210 papers.

0numbers the graph read from it
0cells of the map it votes in
210citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

210 citing papers in PubMed, 340 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. CXCR5Nature communications · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

150 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 4 countries.

Xindong Liu1] Tsinghua University School of Medicine, Beijing 100084, China [2] Department of Immunology, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Xin ChenTsinghua University School of Medicine, Beijing 100084, China.
Bo Zhong1] Department of Immunology, MD Anderson Cancer Center, Houston, Texas 77054, USA [2] College of Life Sciences, Wuhan University, Wuhan 430072, China (B.Z.); SomantiX B.V., Padualaan 8, 3584 CH Utrecht, the Netherlands (L.G.v.d.F.).
Aibo Wang1] Tsinghua University School of Medicine, Beijing 100084, China [2] Department of Immunology, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Xiaohu Wang1] Tsinghua University School of Medicine, Beijing 100084, China [2] Department of Immunology, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Fuliang ChuDepartment of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Roza I NurievaDepartment of Immunology, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Xiaowei YanInstitute for Systems Biology, Seattle, Washington 98103, USA.
Ping ChenLaboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland 20892-1858, USA.
Laurens G van der Flier1] Hubrecht Institute-KNAW and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands [2] College of Life Sciences, Wuhan University, Wuhan 430072, China (B.Z.); SomantiX B.V., Padualaan 8, 3584 CH Utrecht, the Netherlands (L.G.v.d.F.).
Hiroko NakatsukasaNational Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-2190, USA.
Sattva S NeelapuDepartment of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Wanjun ChenNational Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-2190, USA.
Hans CleversHubrecht Institute-KNAW and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands.
Qiang TianInstitute for Systems Biology, Seattle, Washington 98103, USA.
Hai QiTsinghua University School of Medicine, Beijing 100084, China.
Lai WeiState Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou 510275, China.
Chen Dong1] Tsinghua University School of Medicine, Beijing 100084, China [2] Department of Immunology, MD Anderson Cancer Center, Houston, Texas 77054, USA.
Tsinghua University · CNThe University of Texas MD Anderson Cancer Center · USLymphoma Research Foundation · USNational Institutes of Health · USInstitute for Systems Biology · USInSysBio (Russia) · RUNational Eye Institute · USUniversity Medical Center Utrecht · NLUtrecht University · NL

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and ToleranceZIADE000101 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI CHEN, WANJUN · 2009 to 2025
$36.9M
Transcriptional regulation of inflammatory helper T Cell differentiationR01AR050772 · NIAMS · UNIVERSITY OF WASHINGTON · PI DONG, CHEN · 2003 to 2016
$4.5M
Transcriptome and epigenome analysis of helper T cell specification and plasticitRC2AR059010 · NIAMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DONG, CHEN · 2009 to 2010
$2.8M
Effector and memory T follicular helper cellsR01AI106654 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DONG, CHEN · 2013 to 2015
$620k
Intramural NIH HHSNCI NIH HHS P30 CA016672NIAID NIH HHS AI106654NIAID NIH HHS R01 AI106654NIAMS NIH HHS R01 AR050772NIAMS NIH HHS RC2 AR059010
6 · The paper itself

Abstract

In immune responses, activated T cells migrate to B-cell follicles and develop into follicular T-helper (TFH) cells, a recently identified subset of CD4(+) T cells specialized in providing help to B lymphocytes in the induction of germinal centres. Although Bcl6 has been shown to be essential in TFH-cell function, it may not regulate the initial migration of T cells or the induction of the TFH program, as exemplified by C-X-C chemokine receptor type 5 (CXCR5) upregulation. Here we show that expression of achaete-scute homologue 2 (Ascl2)--a basic helix-loop-helix (bHLH) transcription factor--is selectively upregulated in TFH cells. Ectopic expression of Ascl2 upregulates CXCR5 but not Bcl6, and downregulates C-C chemokine receptor 7 (CCR7) expression in T cells in vitro, as well as accelerating T-cell migration to the follicles and TFH-cell development in vivo in mice. Genome-wide analysis indicates that Ascl2 directly regulates TFH-related genes whereas it inhibits expression of T-helper cell 1 (TH1) and TH17 signature genes. Acute deletion of Ascl2, as well as blockade of its function with the Id3 protein in CD4(+) T cells, results in impaired TFH-cell development and germinal centre response. Conversely, mutation of Id3, known to cause antibody-mediated autoimmunity, greatly enhances TFH-cell generation. Thus, Ascl2 directly initiates TFH-cell development.

Indexed as

Cell DifferentiationAnimalsBasic Helix-Loop-Helix ProteinsCell MovementDNA-Binding ProteinsDown-RegulationGerminal CenterHumansInhibitor of Differentiation ProteinsMiceMutationProto-Oncogene Proteins c-bcl-6Receptors, CCR7Receptors, CXCR5Th17 CellsT-Lymphocytes, Helper-InducerASCL2 protein, humanAscl2 protein, mouseBasic Helix-Loop-Helix ProteinsBCL6 protein, humanBcl6 protein, mouseCcr7 protein, mouseCXCR5 protein, humanCXCR5 protein, mouseDNA-Binding ProteinsIdb3 protein, mouseInhibitor of Differentiation ProteinsProto-Oncogene Proteins c-bcl-6Receptors, CCR7Receptors, CXCR5

Identifiers

PMID24463518
PMCPMC4012617
OpenAlexW1995635569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.